Osteoporosis is a disease characterized by increased bone fragility and an elevated risk of fractures. Bisphosphonates, which can inhibit bone resorption and increase BMD, are the first choice for the pharmacological management of osteoporosis. One of the bisphosphonates given by injection is zoledronic acid. Side effects that may arise from administering zoledronic acid include decreased calci…